SOPHiA GENETICS SA SOPH
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 24.27M | 23.31M | 21.69M | 21.71M | 19.46M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 24.27M | 23.31M | 21.69M | 21.71M | 19.46M |
| Cost of Revenue | 8.33M | 8.25M | 6.94M | 7.02M | 6.56M |
| Gross Profit | 15.93M | 15.06M | 14.75M | 14.69M | 12.91M |
| SG&A Expenses | 25.46M | 26.39M | 22.57M | 24.65M | 22.56M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -5.00K | -- | 45.00K | 143.00K |
| Total Operating Expenses | 42.09M | 43.36M | 38.97M | 40.25M | 37.32M |
| Operating Income | -17.82M | -20.05M | -17.28M | -18.54M | -17.86M |
| Income Before Tax | -19.96M | -22.28M | -19.07M | -19.57M | -19.38M |
| Income Tax Expenses | 314.00K | 78.00K | 253.00K | -395.00K | 642.00K |
| Earnings from Continuing Operations | -20.27M | -22.36M | -19.32M | -19.18M | -20.02M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -20.27M | -22.36M | -19.32M | -19.18M | -20.02M |
| EBIT | -17.82M | -20.05M | -17.28M | -18.54M | -17.86M |
| EBITDA | -16.71M | -18.90M | -16.13M | -18.10M | -16.77M |
| EPS Basic | -0.24 | -0.30 | -0.27 | -0.28 | -0.30 |
| Normalized Basic EPS | -0.15 | -0.19 | -0.17 | -0.18 | -0.18 |
| EPS Diluted | -0.24 | -0.30 | -0.27 | -0.28 | -0.30 |
| Normalized Diluted EPS | -0.15 | -0.19 | -0.17 | -0.18 | -0.18 |
| Average Basic Shares Outstanding | 85.51M | 73.84M | 71.14M | 68.50M | 67.79M |
| Average Diluted Shares Outstanding | 85.51M | 73.84M | 71.14M | 68.50M | 67.79M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |